13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001406313
Total reported value
$245.6M
$245.6M
15 檔
199.9%
According to the latest 13F quarterly dataset, P2 Capital Partners, LLC managed an equity portfolio of $245.6M at the end of Q3 2024, spanning 15 distinct U.S. exchange-listed positions.
In Q3 2024, P2 Capital Partners, LLC displayed an active expansion posture, initiating 0 new positions and adding to 8 existing holdings, outstripping position reductions.
In terms of portfolio concentration, the top 5 core holdings (including CBZ, BLKB, ACHC) accounted for 199.9% of total reported equity market value during Q3 2024.
Top Position Liquidated / Trimmed
RCM1USD
前期市值: $135.6M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CBZ | Cbiz Inc | Stock-Other | 13.83% | +0.26% | +63.09% | |
| 2 | BLKB | Blackbaud Inc | Stock-Other | 12.77% | -3.06% | -0.10% | |
| 3 | ACHC | Acadia Healthcare Co Inc | Stock-Other | 11.37% | +1.57% | +3.97% | |
| 4 | IAS | Integral Ad Science Holding | Stock-Other | 9.08% | — | +36.88% | |
| 5 | JBTM | Jbt Marel CORP | Stock-Industrials | 9.00% | -0.42% | +6.67% | |
| 6 | TNC | Tennant Co | Stock-Other | 7.98% | -1.59% | +11.67% | |
| 7 | OPCH | Option Care Health Inc | Stock-Healthcare | 6.95% | — | +33.20% | |
| 8 | LIVN | LivaNova PLC | Stock-Other | 6.30% | -3.79% | +10.53% | |
| 9 | AVNT | Avient CORP | Stock-Materials | 6.00% | — | +20.12% | |
| 10 | FUL | H.b. Fuller Co. | Stock-Materials | 5.54% | — | — | |
| 11 | MIR | Mirion Technologies Inc | Stock-Industrials | 4.23% | — | -28.74% | |
| 12 | ENSG | Ensign Group Inc/the | Stock-Healthcare | 3.78% | — | -11.54% | |
| 13 | ENOV | Enovis CORP | Stock-Other | 2.26% | -0.77% | — | |
| 14 | SITE | Siteone Landscape Supply Inc | Stock-Industrials | 0.53% | — | -82.12% | |
| 15 | SHC | Sotera Health Co | Stock-Other | 0.38% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CBZ | Cbiz Inc | +4.9% | +63.09% | Add |
| 2 | IAS | Integral Ad Science Holding | +3.4% | +36.88% | Add |
| 3 | OPCH | Option Care Health Inc | +2.5% | +33.20% | Add |
| 4 | AVNT | Avient CORP | +1.8% | +20.12% | Add |
| 5 | BLKB | Blackbaud Inc | +1.7% | -0.10% | Trim |
| 6 | JBTM | Jbt Marel CORP | +1.2% | +6.67% | Add |
| 7 | TNC | Tennant Co | +1% | +11.67% | Add |
| 8 | LIVN | LivaNova PLC | +0.6% | +10.53% | Add |
| 9 | FUL | H.b. Fuller Co. | +0.4% | — | Unchanged |
| 10 | ENSG | Ensign Group Inc/the | +0.3% | -11.54% | Trim |
| 11 | ACHC | Acadia Healthcare Co Inc | +0.2% | +3.97% | Add |
| 12 | SHC | Sotera Health Co | +0.1% | — | Unchanged |
| 13 | ENOV | Enovis CORP | 0% | — | Unchanged |
| 14 | MIR | Mirion Technologies Inc | -1.3% | -28.74% | Trim |
| 15 | SITE | Siteone Landscape Supply Inc | -1.8% | -82.12% | Trim |
| 16 | RCM1USD | R1 Rcm Inc | -14.9% | EXIT | Sold out |
According to official SEC Form 13F filings, P2 Capital Partners, LLC reported a total U.S. public equity portfolio value of $245.6M across 15 disclosed positions in Q3 2024.
During Q3 2024, P2 Capital Partners, LLC's top holdings by market value included CBZ (13.8%)、BLKB (12.8%)、ACHC (11.4%). The largest single position, CBZ, represented 13.8% of total portfolio value.
In Q3 2024, P2 Capital Partners, LLC made 13 total portfolio adjustments, initiating 0 new buys, adding to 8 positions, trimming 4 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.